Jayanth Kumar Narayana
Overview
Explore the profile of Jayanth Kumar Narayana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Shen X, Xie Y, Ge A, Lu H, Gu S, et al.
Sci Transl Med
. 2025 Feb;
17(787):eadq4409.
PMID: 40009694
The composition of the gut microbiota in patients with bronchiectasis has been proven to be distinct from that of healthy individuals, and this disrupted gut microbiota can exacerbate lung infections....
2.
Narayana J, Mac Aogain M, Hansbro P, Chotirmall S
Curr Opin Pulm Med
. 2024 Nov;
31(2):135-144.
PMID: 39492755
Purpose Of Review: Advances in DNA sequencing and analysis of the respiratory microbiome highlight its close association with bronchiectasis phenotypes, revealing fresh opportunities for diagnosis, stratification, and personalized clinical intervention....
3.
Mac Aogain M, Tiew P, Jaggi T, Narayana J, Singh S, Hansbro P, et al.
Expert Rev Respir Med
. 2024 May;
18(3-4):111-125.
PMID: 38743428
Introduction: This review summarizes our current understanding of the respiratory microbiome in COPD and Bronchiectasis. We explore the interplay between microbial communities, host immune responses, disease pathology, and treatment outcomes....
4.
Meldrum O, Donaldson G, Narayana J, Ivan F, Jaggi T, Mac Aogain M, et al.
Am J Respir Crit Care Med
. 2024 Feb;
210(3):298-310.
PMID: 38315959
Progressive lung function loss is recognized in chronic obstructive pulmonary disease (COPD); however, no study concurrently evaluates how accelerated lung function decline relates to mucus properties and the microbiome in...
5.
Mac Aogain M, Ivan F, Jaggi T, Richardson H, Shoemark A, Narayana J, et al.
Am J Respir Crit Care Med
. 2024 Jan;
210(1):47-62.
PMID: 38271608
Chronic infection and inflammation shapes the airway microbiome in bronchiectasis. Utilizing whole-genome shotgun metagenomics to analyze the airway resistome provides insight into interplay between microbes, resistance genes, and clinical outcomes....
6.
Mac Aogain M, Narayana J, Chotirmall S
Am J Respir Crit Care Med
. 2023 Jun;
208(5):631-632.
PMID: 37348125
No abstract available.
7.
Gramegna A, Narayana J, Amati F, Stainer A, Wu B, Morlacchi L, et al.
Chest
. 2023 Feb;
164(1):65-68.
PMID: 36803648
No abstract available.
8.
Narayana J, Aliberti S, Mac Aogain M, Jaggi T, Ali N, Ivan F, et al.
Am J Respir Crit Care Med
. 2022 Oct;
207(7):908-920.
PMID: 36288294
Emerging data support the existence of a microbial "gut-lung" axis that remains unexplored in bronchiectasis. Prospective and concurrent sampling of gut (stool) and lung (sputum) was performed in a cohort...
9.
Tiew P, Narayana J, Quek M, Ang Y, Ko F, Poh M, et al.
Eur Respir J
. 2022 Aug;
61(1).
PMID: 35926878
Background: Variable clinical outcomes are reported with fungal sensitisation in chronic obstructive pulmonary disease (COPD), and it remains unclear which fungi and what allergens associate with the poorest outcomes. The...
10.
Narayana J, Tsaneva-Atanasova K, Chotirmall S
Am J Respir Crit Care Med
. 2022 May;
206(4):365-368.
PMID: 35584334
No abstract available.